Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPATA13 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | CITED1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | SOHLH1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | GKAP1 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | ENTPD6 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | C19orf71 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
mRNA | TMTC2 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
mRNA | SERPINB5 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
mRNA | FCER1G | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | BIN3 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |